Infinity Pharmaceuticals Announces Its Participation at Three Investor Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it will be participating in the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012, at 3:00 p.m. ET and in the 2012 Citi Global Healthcare Conference on Monday, February 27, 2012, at 11:00 a.m. ET. Both conferences will take place in New York City. A live webcast of these two conferences will be accessible on the “investors/media” section of the company's website,, and will be available for 30 days following the event.

In addition, Infinity will also be attending the UBS Small/Mid-Cap Conference in Boston, February 28-29, 2012. While there is no formal presentation during the UBS Symposium, management will be available for one-on-one meetings during the conference.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at


Infinity Pharmaceuticals, Inc.
Jaren Irene Madden, 617-453-1336
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here